Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,125,758
+$406,706 QoQ
Shares Held
82,650
-7.7% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 290 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. DNLI ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in DNLI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,125,758 | 82,650 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,719,052 | 89,534 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,975,447 | 180,221 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,445,625 | 99,561 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,427,441 | 102,033 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $341,222 | 16,743 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $215,562 | 7,400 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||